In Pennsylvania, researchers are using genomic profiling to help future treatment of pancreatic cancer, which is the third leading cause of cancer deaths in the United States and has a low survival rate of 8%. One study found a mutation in the anaplastic lymphoma kinase gene and used targeted therapy for the mutated gene. Another study used existing medicines to improve pancreatic cancer outcomes with similar genetic mutations. The key was using the targeted genetic therapy early on as they found patients who had advanced too far with pancreatic cancer did not benefit as much as patients who were in the earlier stages.
Latest article
Pineapple pact shows fruits of collaboration on Earth Day
In California, Dole Packaged Foods has partnered with circular design firm Rais Case and Ananas Anam, creator of pineapple-based textile Piñatex®, to tackle pineapple...
Project converting chicken feathers into cultivated chicken meat concludes first phase
In Italy, a research project looking to grow cells from chicken feathers into chicken meat has concluded its first phase by generating a batch...
Vote for sustainability: Bioplastic dummy ballots used to spread voter awareness
In India, IIT Guwahati has developed 3D-printed dummy ballots made of biobased polylactic acid.
Commissioned by the Systematic Voters' Education and Electoral Participation Cell, the...